Edwards Lifesciences Corporation (EW) Net margin 2016–2025
Edwards Lifesciences Corporation (EW) net profit margin by fiscal year — reported net income divided by reported revenue.
17.7%FY2025 · since FY2016: 19.2% → 17.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 17.7% | -59.1 pp |
| FY2024 | 76.7% | +48.8 pp |
| FY2023 | 28.0% | -6.1 pp |
| FY2022 | 34.1% | +5.4 pp |
| FY2021 | 28.7% | +10.0 pp |
| FY2020 | 18.8% | -5.3 pp |
| FY2019 | 24.1% | +4.7 pp |
| FY2018 | 19.4% | +2.4 pp |
| FY2017 | 17.0% | -2.2 pp |
| FY2016 | 19.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice